Demographics (2)
- AGE - Age of subject (phv00557042.v1.p1)
- SEX - Biological sex (phv00557038.v1.p1)
Disease Events (1)
- TUMOR_STAGE - Tumor stage of sample (phv00557051.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00557044.v1.p1)
Other (14)
- ANALYTE_TYPE - Analyte Type (phv00557048.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00557047.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00557037.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00557050.v1.p1)
- IMDC - International Metastatic Renal Cell Carcinoma Database Consortium risk category (phv00557045.v1.p1)
- IS_TUMOR - Tumor status (phv00557049.v1.p1)
- SAMPLE_ID - Sample ID (phv00557046.v1.p1)
- SAMPLE_ID - Sample ID (phv00557040.v1.p1)
- SAMPLE_TIMEPOINT - Timepoint of sample relative to treatment (phv00557053.v1.p1)
- SEQUENCING_CENTER - Name of center which conducted sequencing (phv00557052.v1.p1)
- SUBJECT_ID - Subject ID (phv00557041.v1.p1)
- SUBJECT_ID - Subject ID (phv00557036.v1.p1)
- SUBJECT_ID - Subject ID (phv00557039.v1.p1)
- THERAPEUTIC_RESPONSE - Response to therapy (phv00557043.v1.p1)